GS
GILEAD SCIENCES INC
GILD· Health Care· BiotechnologyS&P 500
Close · 16/09/2026
147.68
1D
+0.94%52-week range
108.46 – 157.29
Volume
51,87,900.00
Price history
GILD
17/08/2026 to 16/09/2026
O 146.58 H 149.30 L 146.12
1W+1.39%
1M+6.31%
3M+16.07%
6M+2.27%
1Y+31.22%
3Y+91.69%
5Y+105.45%
MAX+117.40%
Fundamentals
as of 16/09/2026- Market cap
- $183.12B
- Shares out
- 1.24B
- P/E (forward)
- 14.53
- EPS (trailing)
- -2.61
- Dividend yield
- 1.65%
- Beta
- 0.35
- Profit margin
- -10.64%
- P/B
- 15.48
- Return on equity
- -27.39%
SEC financial statements
67 quarterly and 19 annual periods through 30/06/2026.
Details
- Ticker
- GILD
- Index
- SP500
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 16/09/2026.
Tracked by Congress
11 filers · 2 on watchlist · 22 buys · 10 sells · 7 options · ?: 3 · D: 11 · R: 18
- 10/05/2024Thomas H TubervilleWBuyoption on GILD$1,001–$15,000
- 10/05/2024Thomas H TubervilleWBuyoption on GILD$1,001–$15,000
- 10/05/2024Thomas H TubervilleWBuyoption on GILD$1,001–$15,000
- 08/05/2024Thomas H TubervilleWSellGilead Sciences, Inc. - Common Stock$1,001–$15,000
- 27/03/2026Alan ArmstrongBuyGilead Sciences, Inc. - Common Stock$1,001–$15,000
- 06/05/2026Jared MoskowitzBuyGilead Sciences, Inc. - Common Stock$1,001–$15,000
- 06/05/2026Jared MoskowitzBuyGilead Sciences, Inc. - Common Stock$1,001–$15,000
- 27/01/2026Josh GottheimerWBuyGilead Sciences, Inc. - Common Stock$1,001–$15,000